tradingkey.logo

Park Ha Biological Technology Co Ltd

PHH
0.385USD
0.0000.00%
Close 02/06, 16:00ETQuotes delayed by 15 min
11.31MMarket Cap
--P/E TTM

Park Ha Biological Technology Co Ltd

0.385
0.0000.00%

More Details of Park Ha Biological Technology Co Ltd Company

Park Ha Biological Technology Co Ltd is an investment holding company primarily engaged in developing private skincare label, direct skincare products sales and franchise alliances promotions. The Company mainly operates its business through two segments. The Products Sales segment is engaged in providing skincare and cosmetic products under the brand name Park Ha as well as offering complimentary after-sales beauty services in physical stores. The Franchise Service segment is engaged in entering franchise agreements with its franchisees, pursuant to which the franchisees are granted permission to open and operate a store under the brand name Park Ha or Geni. The Company's products include Little Blue Injection Serum, Parkha Amino Acid Cleansing Foam and other products. The Company mainly conducts its business in domestic market.

Park Ha Biological Technology Co Ltd Info

Ticker SymbolPHH
Company namePark Ha Biological Technology Co Ltd
IPO dateDec 27, 2024
CEOZhang (Xiaoqiu)
Number of employees31
Security typeOrdinary Share
Fiscal year-endDec 27
Address- -
City- -
Stock exchangeNASDAQ Capital Market Consolidated
Country- -
Postal code- -
Phone- -
Website- -
Ticker SymbolPHH
IPO dateDec 27, 2024
CEOZhang (Xiaoqiu)

Company Executives of Park Ha Biological Technology Co Ltd

Name
Name/Position
Position
Shareholding
Change
Ms. Xiaoqiu Zhang
Ms. Xiaoqiu Zhang
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Ms. Li Wang
Ms. Li Wang
Director
Director
--
--
Ms. Xiaoyan Zhu
Ms. Xiaoyan Zhu
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Xinyu Li
Ms. Xinyu Li
Chief Technology Officer, Product Manager
Chief Technology Officer, Product Manager
--
--
Ms. Yanan Shan
Ms. Yanan Shan
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Qixiong Sheng
Mr. Qixiong Sheng
Independent Director
Independent Director
--
--
Mr. Xiaozhong Yu
Mr. Xiaozhong Yu
Independent Director Nominee
Independent Director Nominee
--
--
Name
Name/Position
Position
Shareholding
Change
Ms. Xiaoqiu Zhang
Ms. Xiaoqiu Zhang
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Ms. Li Wang
Ms. Li Wang
Director
Director
--
--
Ms. Xiaoyan Zhu
Ms. Xiaoyan Zhu
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Xinyu Li
Ms. Xinyu Li
Chief Technology Officer, Product Manager
Chief Technology Officer, Product Manager
--
--
Ms. Yanan Shan
Ms. Yanan Shan
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Qixiong Sheng
Mr. Qixiong Sheng
Independent Director
Independent Director
--
--

Revenue Breakdown

FY2024
FY2023
FY2022
FY2021
Relevant data have not been disclosed by the company yet.
By RegionUSD
Name
Revenue
Proportion
China (Mainland)
2.38M
0.00%
By Business
By Region
Relevant data have not been disclosed by the company yet.

Shareholding Stats

Updated: Mon, Nov 17
Updated: Mon, Nov 17
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Xiaoqiu Holding Ltd
51.91%
Changxin International Ltd Partnership
6.81%
XTX Markets LLC
0.12%
Two Sigma Investments, LP
0.07%
Geode Capital Management, L.L.C.
0.05%
Other
41.04%
Shareholders
Shareholders
Proportion
Xiaoqiu Holding Ltd
51.91%
Changxin International Ltd Partnership
6.81%
XTX Markets LLC
0.12%
Two Sigma Investments, LP
0.07%
Geode Capital Management, L.L.C.
0.05%
Other
41.04%
Shareholder Types
Shareholders
Proportion
Corporation
58.72%
Venture Capital
0.12%
Hedge Fund
0.07%
Investment Advisor/Hedge Fund
0.05%
Research Firm
0.01%
Investment Advisor
0.01%
Other
41.02%

Institutional Shareholding

Updated: Thu, Jan 1
Updated: Thu, Jan 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
18
96.81K
0.26%
-57.60K
2025Q3
15
103.15K
0.30%
+40.70K
2025Q2
9
21.62M
81.98%
-25.58K
2025Q1
8
21.60M
81.90%
-29.47K
2024Q4
6
21.63M
82.55%
+21.63M

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
Xiaoqiu Holding Ltd
19.05M
56.24%
--
--
Feb 24, 2025
Changxin International Ltd Partnership
2.50M
7.38%
--
--
Feb 24, 2025
XTX Markets LLC
43.55K
0.13%
+43.55K
--
Sep 30, 2025
Two Sigma Investments, LP
26.69K
0.08%
+26.69K
--
Sep 30, 2025
Geode Capital Management, L.L.C.
16.85K
0.05%
--
--
Sep 30, 2025
Morgan Stanley & Co. LLC
5.34K
0.02%
-1.68K
-23.94%
Sep 30, 2025
UBS Financial Services, Inc.
5.00K
0.01%
+3.53K
+239.88%
Sep 30, 2025
Morgan Stanley Smith Barney LLC
780.00
0%
+486.00
+165.31%
Sep 30, 2025
RBC Capital Markets Wealth Management
19.00
0%
--
--
Sep 30, 2025
Citadel Advisors LLC
--
0%
-21.23K
-100.00%
Sep 30, 2025
View more

Related ETFs

Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
Invesco Golden Dragon China ETF
0%
Invesco Golden Dragon China ETF
Proportion0%

Dividend

A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data

Stock Splits

Date
Ex-dividend Date
Type
Ratio
No Data
Date
Ex-dividend Date
Type
Ratio
No Data
KeyAI